Ticker Scorecard - LXRX Basics Company: Lexicon Pharmaceuticals, Inc. IPO Date: June 23, 2000 Sector: Healthcare Industry: Biotech Market Cap: $256.66M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.47% Avg Daily Range (30 D): $0.03 | 4.28% Avg Daily Range (90 D): $0.05 | 4.96% Institutional Daily Volume Avg Daily Volume: .85M Avg Daily Volume (30 D): 4.21M Avg Daily Volume (90 D): 4.03M Trade Size Avg Trade Size (Sh.): 178 Avg Trade Size (Sh.) (30 D): 491 Avg Trade Size (Sh.) (90 D): 455 Institutional Trades Total Inst.Trades: 983 Avg Inst. Trade: $1.43M Avg Inst. Trade (30 D): $.63M Avg Inst. Trade (90 D): $.7M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.27M Avg Closing Trade (30 D): $.65M Avg Closing Trade (90 D): $.91M Avg Closing Volume: 164.5K     News Feb 3, 2025 @ 12:00 PM George Medicines appoints Amy Carroll as Senior Vi... Source: N/A Jan 17, 2025 @ 9:53 AM 7MM Type 1 Diabetes Market Drug Forecast and Marke... Source: Researchandmarkets.Com Oct 31, 2024 @ 10:54 PM Lexicon Announces Outcome of FDA Advisory Committe... Source: Lexicon Pharmaceuticals, Inc. Sep 27, 2024 @ 12:00 PM Lexicon to Present Phase 3 Trial Design for Sotagl... Source: N/A Sep 10, 2024 @ 12:00 PM New Secondary Analysis of Phase 3 Data Demonstrate... Source: Lexicon Pharmaceuticals, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.75 $-.18 $-.17 Diluted EPS $-.75 $-.18 $-.17 Revenue $ 5.23M $ 1.75M $ 1.65M Gross Profit $ 4.89M $ 1.68M $ 1.48M Net Income / Loss $ -216.39M $ -64.81M $ -53.43M Operating Income / Loss $ -211.12M $ -63.69M $ -55.35M Cost of Revenue $ .34M $ .07M $ .17M Net Cash Flow $ 13.44M $ -1.07M $ -60.88M PE Ratio     Splits May 21, 2015:   7:1